Role of co-trimoxazole for urinary tract infections in developing countries

Lancet Infect Dis. 2015 Jul;15(7):764-5. doi: 10.1016/S1473-3099(15)00076-6.

Authors

Hakan Leblebicioglu¹, Resat Ozaras², Mustafa Sunbul³

Affiliations

¹ Department of Infectious Diseases and Clinical Microbiology, Ondokuz Mayis University Medical School, Samsun, Turkey. Electronic address: hakanomu@yahoo.com.
² Department of Infectious Diseases and Clinical Microbiology, Istanbul University Cerrahpasa Medical School, Samsun, Turkey.
³ Department of Infectious Diseases and Clinical Microbiology, Ondokuz Mayis University Medical School, Samsun, Turkey.

PMID: 26122444
DOI: 10.1016/S1473-3099(15)00076-6

No abstract available

Publication types

Letter
Comment

MeSH terms

AIDS-Related Opportunistic Infections / prevention & control*
Anti-Infective Agents / therapeutic use*
Antimalarials / therapeutic use*
Chemoprevention / methods*
Humans
Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use*

Substances

Anti-Infective Agents
Antimalarials
Trimethoprim, Sulfamethoxazole Drug Combination